CATrends: Tequilas Marketed as 100% Agave
Ingredient claims come into the limelight.
Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)
Similasan Eye Relief products
Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”
Settled
(Final approval granted)
https://www.homeopathiceyedropsettlement.com/home
Ingredient claims come into the limelight.
Beware of food images wrapped in deception.
The DSA misses the mark.
TINA.org reader takes issue with this product’s deceptive packaging.
Don’t let this company blindside you with its deceptive pricing.